Cell Therapy News/Articles, page-17639

It would be literally impossible to put a price on that if it worked.

Millions of dollars per treatment bare minimum Vs a lifetime of home care (or worse).

$10,000,000 would be reasonable.

The scope of this company, if it can get some of these things to market is frightening.

We would be very lucky to get approval for paediatric and adult aGVHD before Big Pharma comes from the clouds for the CHF and CLBP therapies.

I guess it will all depend on Mr Itescu wanting to fight them off.

I was very much involved in raising a successful shareholder rebellion against a SOA recently.

It may very well be prudent to think about the retail holders on here finding out just what % of retail is prepared to join together along with SI and block any move.

It's 25% as most of you know - realistically 20 - 21% as a lot don't bother voting.

SI has just under 7%

If GG goes with any SOA, it seems from a quick glance we would absolutely need most of the other Top 10 onboard.

Is this a thing you long-term holders have already done?

Thanks